Barely Significant
← all excerpts

Tocilizumab in refractory rheumatoid arthritis: long-term efficacy, safety, and tolerability beyond 2 years.

Biologics · 2016 · PMC4818059 · PMID 27069354

Europe PMCDOI
1
hedged sentence
0.0500
closest p · 1.0× alpha
0.0500
boldest claim

The sentences

did not reach statistical significanceP <0.05actually significant
Among the eleven remaining patients not on lipid-lowering therapy, there was a trend to an increase in mean LDL and cholesterol/HDL ratio in the first 3 months after TCZ was initiated, although this did not reach statistical significance of P <0.05.

also in 75,868 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.